Legal & Compliance - Page 113

New polling reveals broad public support for reining in the Supreme Court, cutting across traditional partisan lines in a rare show of bipartisan agreement. A Strength In Numbers and Verasight poll found

The legal world has long held a special place for Blackacre, the fictional parcel of land used in property law courses across every law school in the country. Now, the mythical estate

The Federal Trade Commission has wrapped up a long-running enforcement action against data broker Kochava and its subsidiary, Collective Data Solutions, finalising a settlement over alleged violations. The case was originally brought

On June 30, 2026, the FDA issued modified risk granted orders to Swedish Match USA, Inc., a wholly owned subsidiary of Philip Morris International Inc., covering 20 ZYN nicotine pouch products. The

Former Hogan Lovells partner and ex-Trump White House special counsel Ty Cobb has delivered his most scathing public attack yet on his former boss over crypto earnings. Cobb appeared on CNN’s OutFront

Building a legal practice on genuine relationships rather than aggressive sales tactics is gaining serious traction among top-performing attorneys. A structured, repeatable system grounded in research on connection, memory, and trust is

On June 24, 2026, the Office of Inspector General for the US Department of Health and Human Services published a Request for Information seeking public input on clinical trial participant remuneration. The

The Supreme Court’s birthright citizenship ruling produced an unexpected dissent from Justice Neil Gorsuch that carries significant implications for the Trump administration. The Court ruled 6-3 that children born in the United

As artificial intelligence reshapes the legal industry, a quiet but fundamental shift is underway in how lawyers create value for the businesses they serve. Writing in Above the Law, lawyer and author

Enanta Pharmaceuticals faced a significant legal setback after the US Court of Appeals for the Federal Circuit affirmed summary judgment invalidating its patent on coronavirus inhibitors. The Federal Circuit ruled the asserted